Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Rat dog micro-cap picks... -- Ignore unavailable to you. Want to Upgrade?

To: xcr600 who wrote (5002)	5/22/2001 4:40:06 PM
From: Bucky Katt	Respond to of 48461

In range for a rat buy-in, ta is turning up. 1.33 is 50 day ma, 2.03 is 200 day ma, last trade was 1.10 Looks good for a run into the 1.75 area, no telling what the time frame might be at this point. The rat buy plan would preclude making any big mistake in case it tanks under a buck.

To: xcr600 who wrote (5002)	5/23/2001 2:02:47 PM
From: Bucky Katt	Read Replies (1) \| Respond to of 48461

ASTM perking, remember last run?, maybe in stride with old rat GENE, GNLB a poor mans play, perhaps. CTB up today, selling out. Sold ALLP yesterday, and of course it popped into 3.70 early... Just received the BIPL annual report, I think it will have a good run over the next 52 weeks, as new testing products are introduced. They are going into some stuff aimed toward food safety & pollution. Amazingly, they are also working with the Dept. of Defense on some stuff, the Dept. of Agriculture, Centers for Disease Control, and the National Cancer Institute on Gene Expression. So, I say it again, BIPL is by far the cheapest way into the genomic research field. However, I want to buy/add at a lower level. Hey, INVN bidding 3.50, will wonders never cease! Added some today @3.35 Also was adding when it was 2.60 2 weeks back. I am looking for a major move, but it needs to take out 3.80 soon, or the rally could stall.